142 related articles for article (PubMed ID: 2506053)
1. Low levels of serum type III procollagen aminoterminal propeptide confirmed type III collagen deficiency in patients without typical clinical symptoms of Ehlers-Danlos type IV.
Dyne KM; Zanaboni G; Annoni G; De Agostini MP; Cetta G
Eur J Clin Invest; 1989 Aug; 19(4):362-6. PubMed ID: 2506053
[TBL] [Abstract][Full Text] [Related]
2. Ehlers-Danlos syndrome type IV: a subset of patients distinguished by low serum levels of the amino-terminal propeptide of type III procollagen.
Steinmann B; Superti-Furga A; Joller-Jemelka HI; Cetta G; Byers PH
Am J Med Genet; 1989 Sep; 34(1):68-71. PubMed ID: 2816989
[TBL] [Abstract][Full Text] [Related]
3. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
[TBL] [Abstract][Full Text] [Related]
4. Ehlers-Danlos syndrome. A variant characterized by the deficiency of pro alpha 2 chain of type I procollagen.
Sasaki T; Arai K; Ono M; Yamaguchi T; Furuta S; Nagai Y
Arch Dermatol; 1987 Jan; 123(1):76-9. PubMed ID: 3800425
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and immunological studies of fibroblasts derived from a patient with Ehlers-Danlos syndrome type IV. Demonstrate reduced type III collagen synthesis.
Aumailley M; Krieg T; Dessau W; Müller PK; Timpl R; Bricaud H
Arch Dermatol Res; 1980; 269(2):169-77. PubMed ID: 7458408
[TBL] [Abstract][Full Text] [Related]
6. Ehlers-Danlos syndrome type VIII: biochemical, stereological and immunocytochemical studies on dermis from a child with clinical signs of Ehlers-Danlos syndrome and a family history of premature loss of permanent teeth.
Dyne KM; Vitellaro-Zuccarello L; Bacchella L; Lanzi G; Cetta G
Br J Dermatol; 1993 Apr; 128(4):458-63. PubMed ID: 8494762
[TBL] [Abstract][Full Text] [Related]
7. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK
Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227
[TBL] [Abstract][Full Text] [Related]
8. Collagen peptides in osteogenesis imperfecta, idiopathic juvenile osteoporosis and Ehlers--Danlos syndrome.
Prószyńska K; Wieczorek E; Olszaniecka M; Lorenc RS
Acta Paediatr; 1996 Jun; 85(6):688-91. PubMed ID: 8816205
[TBL] [Abstract][Full Text] [Related]
9. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
[TBL] [Abstract][Full Text] [Related]
10. Altered secretion of type III procollagen in a form of type IV Ehlers-Danlos syndrome. Biochemical studies in cultured fibroblasts.
Byers PH; Holbrook KA; Barsh GS; Smith LT; Bornstein P
Lab Invest; 1981 Apr; 44(4):336-41. PubMed ID: 6259441
[TBL] [Abstract][Full Text] [Related]
11. Ehlers-Danlos syndrome type IV D: an autosomal recessive disorder.
Sulh HM; Steinmann B; Rao VH; Dudin G; Zeid JA; Slim M; Der Kaloustian VM
Clin Genet; 1984 Mar; 25(3):278-87. PubMed ID: 6705261
[TBL] [Abstract][Full Text] [Related]
12. Biochemical, morphological and stereological study of the dermis in three members of a large family with type IV Ehlers-Danlos syndrome.
Vitellaro-Zuccarello L; Dyne K; Cetta G
Connect Tissue Res; 1989; 23(1):1-17. PubMed ID: 2632142
[TBL] [Abstract][Full Text] [Related]
13. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
[TBL] [Abstract][Full Text] [Related]
14. Impaired secretion of type III procollagen in Ehlers-Danlos syndrome type IV fibroblasts: correction of the defect by incubation at reduced temperature and demonstration of subtle alterations in the triple-helical region of the molecule.
Superti-Furga A; Steinmann B
Biochem Biophys Res Commun; 1988 Jan; 150(1):140-7. PubMed ID: 3337712
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
Stolle CA; Pyeritz RE; Myers JC; Prockop DJ
J Biol Chem; 1985 Feb; 260(3):1937-44. PubMed ID: 2981879
[TBL] [Abstract][Full Text] [Related]
16. Defects in the processing of procollagen to collagen are demonstrable in cultured fibroblasts from patients with the Ehlers-Danlos and osteogenesis imperfecta syndromes.
Minor RR; Sippola-Thiele M; McKeon J; Berger J; Prockop DJ
J Biol Chem; 1986 Jul; 261(21):10006-14. PubMed ID: 3733683
[TBL] [Abstract][Full Text] [Related]
17. Lung collagen in type IV Ehlers-Danlos syndrome: ultrastructural and biochemical studies.
Clark JG; Kuhn C; Uitto J
Am Rev Respir Dis; 1980 Dec; 122(6):971-8. PubMed ID: 7458068
[TBL] [Abstract][Full Text] [Related]
18. Pathomorphological and biochemical alterations in Ehlers-Danlos-syndrome type IV.
Nerlich AG; Stöss H; Lehmann H; Krieg T; Müller PK
Pathol Res Pract; 1994 Aug; 190(7):697-706; discussion 706-7. PubMed ID: 7808968
[TBL] [Abstract][Full Text] [Related]
19. New lethal disease involving type I and III collagen defect resembling geroderma osteodysplastica, De Barsy syndrome, and Ehlers-Danlos syndrome IV.
Jukkola A; Kauppila S; Risteli L; Vuopala K; Risteli J; Leisti J; Pajunen L
J Med Genet; 1998 Jun; 35(6):513-8. PubMed ID: 9643297
[TBL] [Abstract][Full Text] [Related]
20. Patients with Ehlers-Danlos syndrome type IV lack type III collagen.
Pope FM; Martin GR; Lichtenstein JR; Penttinen R; Gerson B; Rowe DW; McKusick VA
Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1314-6. PubMed ID: 1055406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
